GlobalRPh Renal Dosing Masterv7.4
Renal Dosing Master: fast drug lookup
Source review / handoff

Ceftazidime

One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.

Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.

Share or print this source review

1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.

Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.

Clinical context remains essential

Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.

Check source scope before reading a dose

Fortaz - labeled renal guidance

Product / population
Ceftazidime (Fortaz), IM or IV injection
Renal method
Creatinine clearance (CrCl), mL/min
Source revision
DailyMed SPL version 9, posted Sep 13, 2019
Retrieved
2026-11-07
Local review status
Selected renal passages reviewed; independent clinician adjudication pending.

Documented differences and cautions on this drug

All record notes are retained here, including notes about sources not selected in this review.

Fortaz - product and source limitations

Excess exposure may cause encephalopathy, myoclonus or seizures. Verify the relevant dialysis schedule separately.

What to reconcile: Verify the current prescribing information for this presentation.

Selected renal passages reviewed; independent clinician adjudication pending.

Open this note and its source references

Tazicef - product and source limitations

High concentrations during reduced urine output can cause neurologic toxicity. Verify the indication and dialysis modality.

What to reconcile: Apply only to the stated formulation, indication and renal population.

Selected renal passages reviewed; independent clinician adjudication pending.

Open this note and its source references
Official

Fortaz - labeled renal guidance

Open original reference

DailyMed / product prescribing information · Ceftazidime (Fortaz), IM or IV injection

Renal method: Creatinine clearance (CrCl), mL/min
Source date: DailyMed SPL version 9, posted Sep 13, 2019
Retrieved: 2026-11-07

Dose or interval guidance. Use only the product, indication, renal metric and population described in this source.

Selected renal passages reviewed; independent clinician adjudication pending.

Renal guidance: General

Reduce maintenance dosing for impaired renal elimination. Select dose and interval using the adult renal table, the infection severity, and the organism's susceptibility. Excess exposure may cause encephalopathy, myoclonus or seizures. Verify the relevant dialysis schedule separately.

RDM74-fortaz-official-1 · Source locator: Renal guidance: General

Source identity and provenance
Source family
product_label
Source
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=78982c98-7866-49f1-989f-a289c4242358
Retrieved
2026-11-07
Renal-function method
Creatinine clearance (CrCl), mL/min
Source date/version
DailyMed SPL version 9, posted Sep 13, 2019
Hash meaning
SHA-256 of the local selected-source summary
Local summary SHA-256
8e28d393cf98911ddf926499fd051fef26b74a8307e43fa75dce8c25835454fb

Document the clinical decision separately

This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.

GlobalRPh Renal Dosing Master v7.4. Review the retrieval and revision dates attached to each source. Selecting a reference does not imply clinical verification.

Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=ceftazidime&s1=RDM74-fortaz-official&h1=fe68d0811f0fa11c1b88a747930451edb2bb797bb0ba5edc6021d9f5a3b8e413

Top